Luye Pharma focuses on therapeutic areas with the largest and fastest growth in demand — CNS, oncology, cardiovascular, and metabolism. Our key products have a leading position in their respective market segments.
Through real-time fluorescent qPCR and next-generation sequencing (NGS) technologies in combination with data platforms, Luye Diagnostics provides clinical, intelligent, complete solutions in different stages of the disease.
A high-tech enterprise specializing in the research and development, production and sales of preventive, therapeutic, biological preparations, additives and other drugs for animals (farmed animals and pets).